» Articles » PMID: 34515625

Overexpression of GDP Dissociation Inhibitor 1 Gene Associates with the Invasiveness and Poor Outcomes of Colorectal Cancer

Overview
Journal Bioengineered
Date 2021 Sep 13
PMID 34515625
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

GDP dissociation inhibitor ( regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting GDP dissociation. This study evaluated the potential prognostic and predictive value of in colorectal cancer (CRC). To address the prognostic power of , we performed individual and pooled survival analyses on six independent CRC microarray gene expression datasets. -enriched signatures were also analyzed. Kaplan-Meier and Cox proportional analyses were employed for survival analysis. An immunohistochemistry (IHC) analysis was performed to validate the clinical relevance and prognostic significance of the GDI1 protein level in CRC tissue samples. The results revealed that mRNA level was significantly linked with the aggressiveness of CRC, which is compatible with gene set enrichment analysis. A meta-analysis and pooled analysis demonstrated that a higher mRNA expression was dramatically correlated with a worse survival in a dose-dependent manner in CRC patients. Further IHC analysis validated that the protein expression of GDI1 in both cytoplasm and membrane also significantly impacted the outcome of CRC patients. In CRC patients with stage III, chemotherapy significantly reduced the relative risk of death in low- subgroup (hazard ratio (HR) = 0.22; 95% confidence interval (95% CI) 0.09-0.56, = 0.0003), but not in high- subgroup (HR = 0.63; 95% CI 0.35-1.14, = 0.1137). Therefore, both high mRNA and protein levels of GDI1 were significantly related to poor outcomes in CRC patients. may serve as a prognostic biomarker for CRC.

Citing Articles

Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines.

Razumovskaya A, Silkina M, Poloznikov A, Kulagin T, Raigorodskaya M, Gorban N Front Mol Biosci. 2025; 12:1531175.

PMID: 39886381 PMC: 11774744. DOI: 10.3389/fmolb.2025.1531175.


Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer.

Xun D, Li X, Huang L, Zhao Y, Chen J, Qi X J Gastrointest Oncol. 2024; 15(5):2100-2116.

PMID: 39554586 PMC: 11565104. DOI: 10.21037/jgo-24-325.


Disulfidptosis-related prognostic signature correlates with immunotherapy response in colorectal cancer.

Xiao Y, Lin H, Li J, Wu J Sci Rep. 2024; 14(1):81.

PMID: 38168553 PMC: 10762008. DOI: 10.1038/s41598-023-49954-w.


Membrane Trafficking-Related Genes Predict Tumor Immune Microenvironment and Prognosis in Colorectal Cancer.

Ding Z, Han L, Zhang Q, Hu J, Li L, Qian X Biochem Genet. 2023; 62(2):1413-1427.

PMID: 37615899 DOI: 10.1007/s10528-023-10498-3.


The C. elegans anchor cell: A model to elucidate mechanisms underlying invasion through basement membrane.

Kenny-Ganzert I, Sherwood D Semin Cell Dev Biol. 2023; 154(Pt A):23-34.

PMID: 37422376 PMC: 10592375. DOI: 10.1016/j.semcdb.2023.07.002.

References
1.
Suzuki H, Yamamoto E, Yamano H, Nakase H, Sugai T . Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis. Digestion. 2018; 99(1):33-38. DOI: 10.1159/000494410. View

2.
Moon S, Zheng Y . Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 2002; 13(1):13-22. DOI: 10.1016/s0962-8924(02)00004-1. View

3.
Yang J, Yu J . The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell. 2018; 9(5):474-487. PMC: 5960467. DOI: 10.1007/s13238-018-0543-6. View

4.
Lucas C, Barnich N, Nguyen H . Microbiota, Inflammation and Colorectal Cancer. Int J Mol Sci. 2017; 18(6). PMC: 5486131. DOI: 10.3390/ijms18061310. View

5.
Nicolini A, Ferrari P, Duffy M, Antonelli A, Rossi G, Metelli M . Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival. Arch Surg. 2010; 145(12):1177-83. DOI: 10.1001/archsurg.2010.251. View